|
TW201127375A
|
|
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
|
WO2011085188A1
|
|
Pharmaceutical compositions comprising anti-psychotic drugs
|
|
WO2011082426A1
|
|
Controlled release compositions comprising meclizine or related piperazine derivatives
|
|
WO2011066289A1
|
|
Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting
|
|
WO2010096820A1
|
|
Controlled release compositions comprising anti-cholinergic drugs
|
|
TW200938186A
|
|
Orally disintegrating tablet compositions of ranitidine and methods of manufacture
|
|
BRPI0821761A2
|
|
Temazepam Oral Disintegrating Tablet Compositions
|
|
CN101951767A
|
|
Orally disintegrating tablets comprising diphenhydramine
|
|
ZA200901366B
|
|
Drug delivery systems comprising solid solutions of weakly basic drugs
|
|
CA2661683A1
|
|
Drug delivery systems comprising solid solutions of weakly basic drugs
|
|
NZ570039A
|
|
Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
|
|
KR20080104132A
|
|
Drug delivery systems comprising weakly basic drugs and organic acids
|
|
WO2005004919A2
|
|
Extended release systems for macrolide antibiotics
|
|
AU2003298841A1
|
|
Pharmaceutical compositions containing indistinguishable drug components
|
|
US7387793B2
|
|
Modified release dosage forms of skeletal muscle relaxants
|
|
US2008279937A2
|
|
Controlled release potassium chloride tablets
|
